Evaluation of fluvoxamineeffect on tinnitus
Phase 2
- Conditions
- Tinnitus.Tinnitus
- Registration Number
- IRCT2012101811157N1
- Lead Sponsor
- orestan University of Medical Sciences, Vice chancellor for research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
The patients who suffer from sensorineural hearing loss and tinnitus / No contraindication to fluvoxamine /With a written consent form
Exclusion criteria: Using similar drugs / Using other medications that interact with fluvoxamine / Fluvoxamine side effects presentation
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Intensity of tinnitus. Timepoint: Before and one month after intervention. Method of measurement: According to Tinnitus Matching.
- Secondary Outcome Measures
Name Time Method Frequency of tinnitus. Timepoint: Before and one month after intervention. Method of measurement: According to Tinnitus Matching.;Sex. Timepoint: Before intervention. Method of measurement: According to questionnaire.;Tone of tinnitus. Timepoint: Before and one month after intervention. Method of measurement: According to Tinnitus Matching.;Age. Timepoint: Before intervention. Method of measurement: According to questionnaire.;The satisfaction of treatment. Timepoint: After intervention. Method of measurement: According to Visual Analog Scale.